B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PRSS3

MOLECULAR TARGET

serine protease 3

UniProt: P35030NCBI Gene: 56462 compounds

PRSS3 (serine protease 3) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PRSS3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bortezomib0.691
2Sulfaguanidine0.691

About PRSS3 as a Drug Target

PRSS3 (serine protease 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented PRSS3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PRSS3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.